Elovaara I - Search Results

1

Suppression of immune system genes by methylprednisolone in exacerbations of multiple sclerosis. Preliminary results.

Airla N, Luomala M, Elovaara I, Kettunen E, Knuutila S, Lehtimäki T. Airla N, et al. Among authors: elovaara i. J Neurol. 2004 Oct;251(10):1215-9. doi: 10.1007/s00415-004-0516-y. J Neurol. 2004. PMID: 15503100

2

Methylprednisolone reduces adhesion molecules in blood and cerebrospinal fluid in patients with MS.

Elovaara I, Lällä M, Spåre E, Lehtimäki T, Dastidar P. Elovaara I, et al. Neurology. 1998 Dec;51(6):1703-8. doi: 10.1212/wnl.51.6.1703. Neurology. 1998. PMID: 9855526 Clinical Trial.

3

Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy.

Elovaara I, Ukkonen M, Leppäkynnäs M, Lehtimäki T, Luomala M, Peltola J, Dastidar P. Elovaara I, et al. Arch Neurol. 2000 Apr;57(4):546-51. doi: 10.1001/archneur.57.4.546. Arch Neurol. 2000. PMID: 10768630 Clinical Trial.

4

Gene expression profiles in Finnish twins with multiple sclerosis.

Särkijärvi S, Kuusisto H, Paalavuo R, Levula M, Airla N, Lehtimäki T, Kaprio J, Koskenvuo M, Elovaara I. Särkijärvi S, et al. Among authors: elovaara i. BMC Med Genet. 2006 Feb 27;7:11. doi: 10.1186/1471-2350-7-11. BMC Med Genet. 2006. PMID: 16504146 Free PMC article.

5

Intercellular adhesion molecule-1 K/E 469 polymorphism and multiple sclerosis.

Luomala M, Elovaara I, Koivula T, Lehtimäki T. Luomala M, et al. Among authors: elovaara i. Ann Neurol. 1999 Apr;45(4):546-7. doi: 10.1002/1531-8249(199904)45:4<546::aid-ana22>3.0.co;2-v. Ann Neurol. 1999. PMID: 10211485 No abstract available.

6

Plasminogen activator inhibitor 1 gene and risk of MS in women.

Luomala M, Elovaara I, Ukkonen M, Koivula T, Lehtimäki T. Luomala M, et al. Among authors: elovaara i. Neurology. 2000 May 9;54(9):1862-4. doi: 10.1212/wnl.54.9.1862. Neurology. 2000. PMID: 10802801

7

The combination of HLA-DR1 and HLA-DR53 protects against MS.

Luomala M, Elovaara I, Ukkonen M, Koivula T, Lehtimäki T. Luomala M, et al. Among authors: elovaara i. Neurology. 2001 Feb 13;56(3):383-5. doi: 10.1212/wnl.56.3.383. Neurology. 2001. PMID: 11171905

8

A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis.

Luomala M, Lehtimäki T, Elovaara I, Wang X, Ukkonen M, Mattila K, Laippala P, Koivula T, Hurme M. Luomala M, et al. Among authors: elovaara i. J Neurol Sci. 2001 Apr 1;185(2):123-7. doi: 10.1016/s0022-510x(01)00482-8. J Neurol Sci. 2001. PMID: 11311293

9

Interaction between ESR1 and HLA-DR2 may contribute to the development of MS in women.

Mattila KM, Luomala M, Lehtimäki T, Laippala P, Koivula T, Elovaara I. Mattila KM, et al. Among authors: elovaara i. Neurology. 2001 May 8;56(9):1246-7. doi: 10.1212/wnl.56.9.1246. Neurology. 2001. PMID: 11342704 No abstract available.

10

Promoter polymorphism of IL-10 and severity of multiple sclerosis.

Luomala M, Lehtimäki T, Huhtala H, Ukkonen M, Koivula T, Hurme M, Elovaara I. Luomala M, et al. Among authors: elovaara i. Acta Neurol Scand. 2003 Dec;108(6):396-400. doi: 10.1034/j.1600-0404.2003.00165.x. Acta Neurol Scand. 2003. PMID: 14616291

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters